Suurbritannia - inglise - MHRA (Medicines & Healthcare Products Regulatory Agency)

mawdsley-brooks & company ltd - eicosapentaenoic acid; docosahexaenoic acid - oral capsule - 460mg ; 380mg

Suurbritannia - inglise - MHRA (Medicines & Healthcare Products Regulatory Agency)

de pharmaceuticals - eicosapentaenoic acid; docosahexaenoic acid - oral capsule - 460mg ; 380mg

Suurbritannia - inglise - MHRA (Medicines & Healthcare Products Regulatory Agency)

waymade healthcare plc - eicosapentaenoic acid; docosahexaenoic acid - oral capsule - 460mg ; 380mg

Suurbritannia - inglise - MHRA (Medicines & Healthcare Products Regulatory Agency)

viatris uk healthcare ltd - eicosapentaenoic acid; docosahexaenoic acid - oral capsule - 460mg ; 380mg

Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

sterling-knight pharmaceuticals, llc - omega-3-acid ethyl esters (unii: d87ygh4z0q) (omega-3 fatty acids - unii:71m78end5s), 12-hydroxyeicosapentaenoic acid, (12r)- (unii: 78p2zc128s) (12-hydroxyeicosapentaenoic acid, (12r)- - unii:78p2zc128s), 4,7,10,13,16,19-docosahexaenoic acid, (4e,7e,10e,13e,16e,19e)- (unii: zr7nx0z98x) (4,7,10,13,16,19-docosahexaenoic acid, (4e,7e,10e,13e,16e,19e)- - unii:zr7nx0z98x) - luvira is an orally administered prescription probiotic formulation for the clinical dietary management of suboptimal nutritional status in patients where advanced supplementation is required and nutritional supplementation in physiologically stressful conditions for maintenance of good health is needed.

Austraalia - inglise - APVMA (Australian Pesticides and Veterinary Medicines Authority)

troy laboratories pty ltd - linolenic acid | linoleic acid | docosahexaenoic acid | eicosapentaenoic acid | zinc as zinc sulfate | vitamin e as dl-alpha tocopheryl acetate - nutrition & metabolism - cat | dog | bitch | castrate | cat - queen | cat - tom | kitten | puppy - allergic dermatitis | dermatoses - inflamation | fatty acid deficiency | atopy

Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

international brand management, llc - omega-3-acid ethyl esters (unii: d87ygh4z0q) (omega-3 fatty acids - unii:71m78end5s) - omega-3-acid ethyl esters 1 g in 1 g - each capsule contains 1 gram of omega-3-acid ethyl esters liquid concentrate consisting of at least 900 mg of omega-3-acid ethyl esters.

Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

atlantic biologicals corps - omega-3-acid ethyl esters (unii: d87ygh4z0q) (omega-3 fatty acids - unii:71m78end5s) - omega-3-acid ethyl esters 900 mg - lovaza® (omega-3-acid ethyl esters) is indicated as an adjunct to diet to reduce triglyceride (tg) levels in adult patients with severe (greater than or equal to 500 mg per dl) hypertriglyceridemia (htg). usage considerations: patients should be placed on an appropriate lipid-lowering diet before receiving lovaza and should continue this diet during treatment with lovaza. laboratory studies should be done to ascertain that the lipid levels are consistently abnormal before instituting therapy with lovaza. every attempt should be made to control serum lipids with appropriate diet, exercise, weight loss in obese patients, and control of any medical problems such as diabetes mellitus and hypothyroidism that are contributing to the lipid abnormalities. medications known to exacerbate hypertriglyceridemia (such as beta blockers, thiazides, estrogens) should be discontinued or changed if possible prior to consideration of triglyceride-lowering drug therapy. limitations of use: the effect of lovaza on the risk for

Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

avera mckennan hospital - omega-3-acid ethyl esters (unii: d87ygh4z0q) (omega-3 fatty acids - unii:71m78end5s) - omega-3-acid ethyl esters 900 mg

Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

trigen laboratories, inc. - omega-3 fatty acids (unii: 71m78end5s) (omega-3 fatty acids - unii:71m78end5s), linoleic acid (unii: 9kjl21t0qj) (linoleic acid - unii:9kjl21t0qj), ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), cholecalciferol (unii: 1c6v77qf41) (cholecalciferol - unii:1c6v77qf41), .alpha.-tocopherol acetate, dl- (unii: wr1wpi7ew8) (.alpha.-tocopherol, dl- - unii:7qwa1rio01), folic acid (unii: 935e97boy8) (folic acid - unii:935e97boy8), pyridoxine hydrochloride (unii: 68y4cf58bv) (pyridoxine - unii:kv2 - omega-3 fatty acids 330 mg - ultimatecare one is indicated to provide vitamin/mineral and omega-3 fatty acid supplementation throughout pregnancy, during the postnatal period for both lactating and non-lactating mothers, and throughout the childbearing years. it is also useful for improving nutritional status prior to conception. this product is contraindicated in patients with known hypersensitivity to any of the ingredients.